Perjeta Infusion 420 mg Injection

Description

Perjeta Infusion (420 mg/14 mL, 1 Vial)

Description: Perjeta (pertuzumab) is a prescription medication.

used for the treatment of Perjeta Infusion 420 price  mgcertain types of cancer, particularly HER2-positive breast cancer.

It is a monoclonal antibody that works by Perjeta Infusion 420 mg online blocking the HER2 receptor,

which is involved in cancer cell growth and survival. This infusion is typically administered intravenously in a healthcare setting, usually in combination with other cancer treatments like trastuzumab and chemotherapy.

Drug Class: HER2/neu receptor antagonist (monoclonal antibody)Form: Concentrate for solution for intravenous (IV) infusion (clear, colorless to pale brown solution).

Metastatic Breast Cancer: Administered in combination with trastuzumab and docetaxel for patients who are naive to either anti-HER2 therapy or chemotherapy for metastatic breast cancer Neoadjuvant Therapy: Given as an initial treatment modality prior to surgery for locally advanced, inflammatory, or early stage breast cancer Adjuvant Therapy: Given post- operatively for early breast cancer at high risk of recurrence.

While traditional chemotherapy does not target any particular mechanism, Perjeta is a biological agent used as an immune therapy to block the HER2 dimerization domain outside the cell. Thus, it prevents HER2 receptors from binding with HER3 and HER4 receptors to prevent the growth and proliferation of tumor cells.

Pregnancy Warnings: The use of this medication is known to harm the fetus and can result in congenital anomalies. Appropriate measures should be taken to prevent pregnancy.

Adverse Drug Reaction: Commonly experienced side effects include diarrhea, alopecia, nausea, tiredness, rash, and neutropenia. Infusion reaction: May experience hypersensitivity reactions during the course of the treatment or infusion